Analyst Ratings for NxStage Medical (NXTM)

NXTM Rating Summary

NXTM Price Target Summary

* Over Last 12-Mos
  |   Expand Research on NXTM
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $23.17 (+42.3%) * Over Last 12-Mos
Rating Score: 6.2 / 10   Percentile Rank: 68%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
3/31/2016 Piper Jaffray New Coverage Overweight
(N/A)
18.50
(23.00)
14.96 16.28 8.82% Details
12/18/2015 BTIG
» Updated 2/11/2016
New Coverage Buy
(N/A)
27.00
(N/A)
20.15 16.28 -19.21% Details
Like NXTM Ratings? Also take a look at FMS, BAX

NXTM Ratings News